Long-Term Debt

9 Months Ended

Sep. 30, 2022

A summary of long-term debt follows (in millions):


	September 30, 2022		December 31, 2021

Senior secured term loan (1)	$	1,519.6	$	1,530.7
6.750% senior unsecured notes due 2025	370.0		370.0
10.000% senior unsecured notes due 2027	545.0		545.0
Notes payable and other secured loans	215.3		145.0
Finance lease obligations	584.0		364.6
Less: unamortized debt issuance costs and discounts	(14.4)		(16.5)
Total debt	3,219.5		2,938.8
Less: Current maturities	116.9		60.4
Total long-term debt	$	3,102.6	$	2,878.4

(1)Includes unamortized fair value discount of $2.5 million and $3.0 million as of September 30, 2022 and December 31, 2021, respectively.

The increase in finance lease obligations is primarily a result of the modification of certain existing facility real estate leases that were previously classified as operating leases. See Note 4. "Leases" for further discussion.

The increase in notes payable and other secured loans as well as current maturities includes certain debt assumed as part of the purchase price for a surgical hospital in September 2022. See Note 2. "Acquisitions and Disposals" for further discussion.

Revolving Credit Facility

On August 18, 2022, the Company entered into an amendment to the credit agreement governing its revolving credit facility (the "Revolver"), which amended and supplemented the credit agreement, dated as of August 31, 2017 (the "Credit Agreement"), to provide a $140.0 million increase in the outstanding commitments under the Revolver.

As of September 30, 2022, the Company's availability on its Revolver was $342.0 million (including outstanding letters of credit of $8.0 million). There were no outstanding borrowings under the Revolver as of both September 30, 2022 and December 31, 2021.